Ledger.Open graph →
SEC Form D · filed October 10, 2017

Ribon Therapeutics, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Laurence Lasky · Lexington, MADirectorVictoria M. Richon · Lexington, MAExec · DirectorJonathan M. Root · Lexington, MADirectorDavid M. Cordo · Lexington, MAExecCameron M. Wheeler · Lexington, MADirectorDeborah A. Gillotti · BOULDER, CODirectorSteve A. Tran · BOULDER, COExec · DirectorEugene S. Rosenfelt · San Francisco, CAExecCharles N. Corfield · BOULDER, CODirectorLarry A. Schwartz · BOULDER, CODirectorJohn Garofalo · Concord, MADirectorStefan Kowski · London, United KingdomDirectorBastian Lueken · London, United KingdomDirectorStephen Peel · London, United KingdomExec · DirectorDong Shin Kim · SAN MATEO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗